tradingkey.logo

Burning Rock Biotech Ltd

BNR
查看详细走势图
34.000USD
+3.340+10.91%
收盘 02/06, 16:00美东报价延迟15分钟
306.98M总市值
亏损市盈率 TTM

Burning Rock Biotech Ltd

34.000
+3.340+10.91%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+10.91%

5天

-0.18%

1月

+45.30%

6月

+398.53%

今年开始到现在

+68.73%

1年

+424.69%

查看详细走势图

TradingKey Burning Rock Biotech Ltd股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Burning Rock Biotech Ltd当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗服务供应商行业排名63/75位。机构持股占比非常高,中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Burning Rock Biotech Ltd评分

相关信息

行业排名
63 / 75
全市场排名
365 / 4521
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Burning Rock Biotech Ltd亮点

亮点风险
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
业绩增长期
公司处于发展阶段,最新年度总收入71.08M美元
估值低估
公司最新PE估值-20.91,处于3年历史低位
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值31.72K

分析师目标

根据 0 位分析师
--
评级
--
目标均价
--
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Burning Rock Biotech Ltd新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Burning Rock Biotech Ltd简介

Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
公司代码BNR
公司Burning Rock Biotech Ltd
CEOHan (Yusheng)
网址https://www.brbiotech.com/
KeyAI